story of the week
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1- and BRCA2-Mutation Carriers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
JAMA 2017 Jun 20;317(23)2402-2416, KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, MJ Roos-Blom, S Jervis, FE van Leeuwen, RL Milne, N Andrieu, DE Goldgar, MB Terry, MA Rookus, DF Easton, AC Antoniou, , L McGuffog, DG Evans, D Barrowdale, D Frost, J Adlard, KR Ong, L Izatt, M Tischkowitz, R Eeles, R Davidson, S Hodgson, S Ellis, C Nogues, C Lasset, D Stoppa-Lyonnet, JP Fricker, L Faivre, P Berthet, MJ Hooning, LE van der Kolk, CM Kets, MA Adank, EM John, WK Chung, IL Andrulis, M Southey, MB Daly, SS Buys, A Osorio, C Engel, K Kast, RK Schmutzler, T Caldes, A Jakubowska, J Simard, ML Friedlander, SA McLachlan, E Machackova, L Foretova, YY Tan, CF Singer, E Olah, AM Gerdes, B Arver, H OlssonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.